Press release
Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics
Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology SAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- Illumina,
About this update from Illumina, Inc.
[{"type":"text","content":"Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology\nSAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1. Dr. Knudsen will participate in an on-stage conversation with Dr. Phil Febbo, Illumina's Chief Medical Officer, about the landscape of cancer treatment and research, including what is currently being done to support the prevention, detection, and treatment of cancer.\n\n \n \n \n \n \n \n\n \nDuring the discussion, Dr. Knudsen will share her experience with the rapidly growing and groundbreaking use of clinical genomics in oncology, including what gaps still need to be addressed. She will also share her thoughts on the critical role of the public and private sector in advocating for the use of clinical genomics in oncology.\n\"Dr. Knudsen and the American Cancer Society are incredible advocates for cancer patients and their loved ones,\" said Dr. Phil Febbo. \"As genomics continues to revolutionize how we detect, diagnose, and treat cancer, it will be fabulous to talk to Dr. Knudsen about how cancer genomics can best improve patient outcomes.\" \nIllumina previously announced that former U.S. President Barack Obama will headline the inaugural forum in a fireside chat on the evening of Wednesday, September 28. Twelve years after the passage of the Affordable Care Act, Obama will discuss the continued need for equity, accessibility, and smarter healthcare to improve the human condition. Additionally, on September 30, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, will deliver a keynote address on the remarkable potential of genomics to change the trajectory of global health.\nOther IGF key themes include:\nHow genomic technology is driving more informed, proactive, and personalized patient diagnosis and treatment in clinicsWays in which whole-genome sequencing is revolutionizing patient careThe role of genomics in supporting healthcare's quadruple aim to improve population health, reduce costs, enhance the patient experience, and improve provider satisfactionIGF will take place in San Diego from September 28 through October 1. Fo...